secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2025-05-21T23:59:59+00:00
Accession:  0001213900-25-046436
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Oramed extends $20M stock buyback program through June 2026
-----------------------------------------------------------

- Board extended share repurchase program by one year, now expiring June 2026.
- Maximum authorization remains $20M; $2.494M in shares repurchased to date.
- Repurchases may occur via open market or private transactions; no obligation to buy.
- Board may terminate, increase, or decrease authorization at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390025046436/0001213900-25-046436-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390025046436/ea0243059-8k_oramed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-046436

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer